This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Philippe Alen
Head of Cardiovascular Business Development Licensing & Alliance Management at Bayer SA-NV


Dr. Alen has over 20 years experience in biopharma R&D, global marketing and business development. He is currently Vice President and Head of Business Development, Licensing and Alliance Management for Cardiovascular Diseases at Bayer. In this role he oversees all partnering activities for cardiology, nephrology and adjacent disease states from early stage research and technologies to late development and commercial products. Prior to joining Bayer he was responsible for Business Development at Janssen Pharmaceuticals, supporting the Infectious Disease and Vaccines therapeutic area . He received his Pharm.D. and Ph.D. form the Catholic University of Leuven, Belgium, and MBA from Drexel University in Philadelphia.

Agenda Sessions

  • Cardiovascular and nephrology: a renewed interest

    On Demand